---
created: 2025-04-13
updated: 2025-04-13T10:53
id: H);%VP[}I2
specialty: pharmaco
specialty_id: 359
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::01-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites::pyrimidine-synthesis-inhibitors::methotrexate
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::01-antimetabolites::01-methotrexate,-leucovorin,-5-fluorouracil,-hydroxyurea::zanki-extra
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
Since methotrexate is a(n) **weak acid**, a methotrexate overdose can be treated with **Bicarbonate** in order to **alkalinize** urine

---

# Answer
When methotrexate passes the glomerular filtration barrier, it can be trapped in the urine if urine is alkalinized - this is because weak acids (methotrexate) can be ionized at basic pH and thus trapped in the urine (preventing reabsorption)